David Lamond - Dec 5, 2023 Form 4 Insider Report for Quince Therapeutics, Inc. (QNCX)

Role
Director
Signature
/s/ Brendan Hannah, Attorney-in-Fact for David Lamond
Stock symbol
QNCX
Transactions as of
Dec 5, 2023
Transactions value $
$58,134
Form type
4
Date filed
12/7/2023, 06:30 PM
Previous filing
Dec 1, 2023
Next filing
Dec 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QNCX Common Stock Purchase $19.3K +19.1K +0.86% $1.01 2.24M Dec 5, 2023 By Blue Devil Trust dated 12/03/2010 F1
transaction QNCX Common Stock Purchase $19.5K +19.1K +0.85% $1.02 2.26M Dec 6, 2023 By Blue Devil Trust dated 12/03/2010 F1, F2
transaction QNCX Common Stock Purchase $19.3K +19.1K +0.85% $1.01 2.28M Dec 7, 2023 By Blue Devil Trust dated 12/03/2010 F1
holding QNCX Common Stock 302K Dec 5, 2023 Direct
holding QNCX Common Stock 1.73M Dec 5, 2023 By David A. Lamond Trust dated 2006 F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the "Trust") and holds sole voting and dispositive power with respect to the shares held of record by the Trust.
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.99 to $1.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range.
F3 Mr. Lamond is the trustee of David A. Lamond Trust dated 2006 (the "2006 Trust") and holds sole voting and dispositive power with respect to the shares held of record by the 2006 Trust.